Breaking News

Biogen Idec Reveals Restructuring Details

Operational changes include relocating its U.S. workforce from six current locations into three existing facilities in Weston and Cambridge, MA, and Research Triangle Park, NC.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Biogen Idec has revealed the strategic, operational and organizational changes related to its previously announced restructuring aimed at increasing focus and efficiency for future growth. The company will focus on neurology, cease development efforts in cardiovascular medicine, and outlicense its oncology assets. The company will also seek to leverage its commercial strengths and expertise in developing and manufacturing biologics through strategic partnerships. Operational changes include r...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters